Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia

AIDS

Volumn 14, Issue 4, 2000, Pages 441-448

  O'Donovan, Diarmuid ^a   Ariyoshi, Koya ^a   Milligan, Paul ^a   Ota, Martin ^a   Yamuah, Lawrence ^a   Sarge Njie, Ramu ^b   Whittle, Hilton ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b NONE

Author keywords

CD4 cell count; Gambia; HIV 1; HIV 2; Mother to child transmission; Plasma virus; Vertical transmission

Indexed keywords

CD4 ANTIGEN;

ADULT; ARTICLE; CELL COUNT; CHILD; CONTROLLED STUDY; FEMALE; GAMBIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PERINATAL MORTALITY; POLYMERASE CHAIN REACTION; PRENATAL PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; STATISTICS; STILLBIRTH; VIRUS LOAD; VIRUS TRANSMISSION;

CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; GAMBIA; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL;

EID: 0034030453     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200003100-00019     Document Type: Article

References (41)

1. 1. European Collaborative Study. Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS 1996, 10:1675-1681.
2. 2. Dickover RE, Garatty EM, Hermann SA, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. J Am Med Assoc 1996, 275:599-605.
3. 3. Witkor SZ, Ekpini E, Nduati RW. Prevention of mother-to-child transmission of HIV-1 in Africa. AIDS 1997, 11(Suppl B):S79-S87.
4. 4. Ryder RW, Nsa W, Hassig SE, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med 1989, 320:637-1642.
5. 5. Adjorlolo-Johnson G, de Cock KM, Ekpini E, et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. J Am Med Assoc 1994, 272:462-466.
6. 6. Bobat R, Coovadia H, Coutsoudis A, Moodley D. Determinants of mother to child transmission of human immunodeficiency type 1 infection in a cohort from Durban, South Africa. Paediatr Infect Dis J 1996, 15:604-610.
7. 7. Working group on mother-to-child transmission of HIV-1 in Africa, America and Europe. Results from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 8:506-510.
8. 8. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992, 339:1007-1012.
9. 9. Weiser B, Nachman S, Tropper P, et al. Quantitation of human immunodeficiency virus type 1 during pregnancy: relationship of viral titer to mother-to-child transmission and stability of viral load. Proc Natl Acad Sci, USA 1994, 91:8031-8041.
10. 10. Semba RD, Miotti PG, Chiphangwi JD, et al. Infant mortality and maternal vitamin A deficiency during human immunodeficiency virus infection. Clin Infect Dis 1995, 21:966-972.
11. 11. Bloland PB, Wirima JJ, Steketee RW, Chilima B, Hightower A, Breman JG. Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection. AIDS 1995, 9:721-726.
12. 12. Ekpini ER, Witkor SZ, Satten GA, et al. Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Cote D'Ivoire. Lancet 1997, 349:1054-1059.
13. 13. Leroy V, Newell M-L, Dabis F, et al. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Lancet 1998, 352:597-600.
14. 14. Kestens L, Brattegaard K, Adjorlolo G et al. Immunological comparison of HIV-1, HIV-2 and dually reactive women delivery in Abidjan, Côte D'Ivoire. AIDS 1992, 6:803-807.
15. 15. de Cock KM, Adjorlolo G, Ekpini E, et al. Epidemiology and transmission of HIV-2. J Am Med Assoc 1993, 270:2083-2086.
16. 16. Whittle HC, Ariyoshi K, Rowland-Jones S. HIV-2 and T cell recognition. Curr Opin Immunol 1998, 10:382-387.
17. 17. Andreasson P-A, Dias F, Naucler A, Andersson S, Biberfeld G. A prospective study of vertical transmisison of HIV-2 in Bissau, Guinea-Bissau. AIDS 1993, 7:989-993.
18. 18. Ricard D, Wilkins A, Ngom PT, et al. The effects of HIV-2 infection in a rural area of Guinea-Bissau. AIDS 1994; 8:977-982.
19. 19. Berry N, Ariyoshi K, Jobe O, et al. HIV-2 proviral load measured by quantitative PCR correlates with CD4+ lymphopenia in HIV-2 infected individuals. AIDS Res Hum Retroviruses 1994, 8:1031-1037.
20. 20. Berry N, Ariyoshi K, Jaffar S, et al. Low peripheral blood viral HIV-2 RNA in individuals with high CD4+ lymphocyte counts differentiates HIV-2 from HIV-1 infections. J Hum Virol 1998, 1:457-468.
21. 21. Dabis F, Msellati P, Dunn D, et al. Estimating the rate of mother-to-child transmission of HIV. Report of a workshop on methodological issues Ghent (Belgium), 17-20 February 1992. AIDS 1993, 7:1139-1148.
22. 22. Ota MOC, O'Donovan D, Alabi AS, et al. Maternal HIV-1 and HIV-2 infection and child survival in The Gambia. AIDS 2000; 14:435-439.
23. 23. Copas, JB. Local likelihood based on kernel censoring. J Roy Stat Soc Ser B 1995, 57:221-235.
24. 24. Stata Corp. Stata Statistical Software: Release 5.0. College Station, TX: Stata Corp.; 1997.
25. 25. Numerical Algorithms Group. Numerical Algorithms Group NAG Fortran Workstation Library. Oxford, UK: NAG Ltd; 1996.
26. 26. Bulterys M, Chao A, Dushimimana A, et al. Multiple sexual partners and mother to child transmission of HIV-1. AIDS 1993, 7:1639-1645.
27. 27. Datta P, Embree JE, Kreiss JK, et al. Mother-to-child transmission of human immunodeficiency virus type 1: report from Nairobi study. J Infect Dis 1994, 170:1134-1140.
28. 28. Taha TET, Miotti P, Liomba G, Dallabetta G, Chiphangwi J. HIV, maternal death and child survival in Africa. AIDS 1996, 10:112-113.
29. 29. Wilkins A, Hayes R, Alonso P, et al. Risk factors for HIV-2 infection in The Gambia. AIDS 1991, 5:1529-1530.
30. 30. Poulsen A-G, Aaby P, Larsen O, et al. Nine year HIV-2 associated mortality in an urban community in Bissau, West Africa. Lancet 1997, 349:911-991.
31. 31. Mulder DW, Nunn AJ, Kamabi A, et al. Two year HIV-1 associated mortality in a Ugandan rural population. Lancet 1994, 343:1021-1023.
32. 32. Simon F, Matheron S, Tamalt C, et al. Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993, 7:1411 -1417.
33. 33. N'Gom PT, Jaffar S, Ricard D, et al. Immune stimulation by syphilis, malaria and HIV-2 infection in villagers in West Africa. Br J Biomed Sci 1997, 54:251-255.
34. 34. Hoffman IF, Jere CS, Taylor TE, et al. The effect of P. falciparum malaria on HIV-1 blood plasma concentration. AIDS 1999, 13:87-494.
35. 35. Nduati RW, John GC, Richardson BA, et al. Human immunodeficiency virus type 1-infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J Infect Dis 1995, 172:1461-1468.
36. 36. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose neviraprine compared with zidovudine for prevention of mother to child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999, 354: 795-802.
37. 37. Marseille E, Kahn JG, Mmiro F, et al. Cost effectiveness of single dose neviraprine regime for mothers and babies to decrease HIV-1 transmission in sub-Saharan Africa. Lancet 1999; 354:803-809.
38. 38. Graham MJ, Newell M-L. Seizing the opportunity: collaborative initiatives to reduce HIV and maternal mortality. Lancet 1999, 353:836-839.
39. 39. Lunn PG, Prentice AM, Austin S, Whitehead RG. Influence of maternal diet on plasma prolactin levels during lactation. Lancet 1980, 1:623-625.
40. 40. Biggar RJ, Miotti PG, Taha TE, et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 1996, 347:1647-1650.
41. 41. Fawzi W, Msamanga GI, Spiegelman D, et al. Randomized trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1 infected women in Tanzania. Lancet 1998, 351:1477-1482.